Catalposide

TargetMol
Product Code: TAR-TN3609
Supplier: TargetMol
CodeSizePrice
TAR-TN3609-1mg1mg£254.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN3609-2mg2mg£378.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN3609-5mg5mg£621.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN3609-10mg10mg£855.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN3609-25mg25mg£1,235.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN3609-50mg50mg£1,645.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Catalposide is a potent inducer of (HO)-1 isolated from Catalpa ovate G. Don (Bignoniaceae). Catalposide possesses antioxidant, anti-apoptotic, anti-microbial, anti-tumoral, and anti-inflammatory properties.
CAS:
6736-85-2
Formula:
C22H26O12
Molecular Weight:
482.43
Pathway:
Autophagy; DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism; NF-κb; Apoptosis; MAPK
Purity:
0.9982
SMILES:
C(O)[C@@]12[C@@]3([C@]([C@H](OC(=O)C4=CC=C(O)C=C4)[C@@]1(O2)[H])(C=CO[C@H]3O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[H])[H]
Target:
ERK; IL Receptor; TNF; NOS; NF-κB; NO Synthase; PPAR; Autophagy

References

Inhibition of inducible nitric oxide synthesis by catalposide from Catalpa ovata. Planta Med. 2002 Aug;68(8):685-9. Electrochemical and spectrometric study of antioxidant activity of pomiferin, isopomiferin, osajin and catalposide. J Pharm Biomed Anal. 2008 Sep 10;48(1):127-33. Inhibition of TNF-alpha, IL-1beta, and IL-6 productions and NF-kappa B activation in lipopolysaccharide-activated RAW 264.7 macrophages by catalposide, an iridoid glycoside isolated from Catalpa ovata G. Don (Bignoniaceae). Int Immunopharmacol. 2002 Jul;2(8):1173-81.